-
Minister of Health pocket book – March 2025
Health Portfolio highlights -
Drinking water screening value for perfluorononanoic acid (PFNA) – Technical summary
A drinking water screening value of 20 ng/L (0.000020 mg/L) is established for perfluorononanoic acid (PFNA) -
Compliance Verification Project 2021-2022: Toys Regulations (Children’s Costumes)
The purpose of this Compliance Verification (CV) project was to verify industry's compliance of children's costumes with specific flammability and packaging requirements of the... -
Consumer Information – Cannabis
Cannabis contains substances that affect the brain and body, including THC and CBD. THC causes the intoxicating effects of cannabis. CBD is not intoxicating and may reduce some... -
Terms of Reference – Science Advisory Committee on Health Products...
Terms of reference for the Science Advisory Committee on Health Products Containing Cannabis. -
Updated - Guidance Document: Preparation of Regulatory Activities in the...
This document defines the filing requirements and provides guidance on the structure, content and format of regulatory activities filed in “non-eCTD electronic-only” format. -
Guidelines for Canadian Drinking Water Quality: Supporting Documents – Malathion
The maximum acceptable concentration (MAC) for malathion in drinking water is 0.19 mg/L (190 µg/L). -
Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk...
A Health Canada safety review was carried out as a follow-up assessment on the potential risk of retinal detachment with the use of oral fluoroquinolones. Health Canada's... -
Chemicals Management Plan
The Chemicals Management Plan (CMP) is a Government of Canada initiative aimed at reducing the risks posed by chemicals to Canadians and their environment. -
Health Product InfoWatch: January 2024
The following is a list of health product advisories, type I drug recalls and summaries of completed safety reviews published in December 2023 by Health Canada. -
Preparation of veterinary Drug Identification Number submissions
This page provides information to assist veterinary drug manufacturers (sponsors) in preparing a well-structured DIN submission to facilitate screening and review by Health... -
Guidance Document: Pre-market Requirements for Medical Device Cybersecurity
Health Canada considers cybersecurity a component of the medical device's design and lifecycle that can affect the safety and effectiveness of the medical device. Manufacturers... -
Registration Decision RD2021-05, Picarbutrazox and VAYANTIS Seed Treatment
This decision is consistent with the Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment, which contains a detailed evaluation of the... -
Regulatory Directive: Plant Growth Regulators
The purpose of this document is to define the scope of plant growth regulators subject to regulation under the Pest Control Products Act and Regulations. -
Notice: Classification of Non-medicated Eyewashes
Classification of a therapeutic product determines whether it is regulated as a drug [that is (i.e.) pharmaceutical, biologic, natural health product] or a medical device. The... -
Growing cannabis at home safely
Safety and security considerations when producing cannabis for your own medical purposes. -
Cannabis: lower your risks
Tips to lower your risks when consuming cannabis, either inhaled or ingested. -
Consumer Product Enforcement Summary Report: Cyclical Enforcement Project...
The purpose of this Cyclical Enforcement (CE) project was to verify industry’s compliance of toys with specific requirements of the Toys Regulations. -
Siloxanes Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 6 of 7 substances referred to collectively as the... -
Safe Food Handling for Children Ages 5 and Under
Children aged 5 and under are at increased risk for food poisoning and related health complications. This is because their immune system is still developing and they cannot...